Close Menu

NEW YORK (GenomeWeb) – Quidel reported after the close of the market on Wednesday that its third quarter revenues rose 3 percent year over year.

For the three months ended Sept. 30, revenues increased to $50.9 million from $49.3 million in Q3 2016, beating the average analyst expectation for revenues of $50.3 million.

In the prior-year quarter, Quidel received a final milestone-based cash payment of $3.8 million dollars from the Bill and Melinda Gates Foundation. Excluding that amount, revenues increased by 12 percent and were driven by immunoassay sales, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.